| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant treatment of colon cancer with microsatellite instability – the state of the art
|
Oneda, Ester
|
|
|
169 |
C |
p.
|
article
|
| 2 |
An analysis of the evidence underpinning the national comprehensive cancer network practice guidelines
|
Love, Mitchell
|
|
|
169 |
C |
p.
|
article
|
| 3 |
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib
|
Awada, Ahmad
|
|
|
169 |
C |
p.
|
article
|
| 4 |
Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes
|
Laukhtina, Ekaterina
|
|
|
169 |
C |
p.
|
article
|
| 5 |
Editorial Board
|
|
|
|
169 |
C |
p.
|
article
|
| 6 |
Emerging role of exosomes as biomarkers in cancer treatment and diagnosis
|
Hanjani, Niloofar Asadi
|
|
|
169 |
C |
p.
|
article
|
| 7 |
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients
|
Malapelle, Umberto
|
|
|
169 |
C |
p.
|
article
|
| 8 |
ESO's career development program (2002-2021): Presentation and evaluation
|
Pavlidis, Nicholas
|
|
|
169 |
C |
p.
|
article
|
| 9 |
Evolving pancreatic cancer treatment: From diagnosis to healthcare management
|
Milella, Michele
|
|
|
169 |
C |
p.
|
article
|
| 10 |
Factor Xa inhibitors versus low molecular weight heparin for the treatment of cancer associated venous thromboembolism; A meta-analysis of randomized controlled trials and non-randomized studies
|
Hussain, Maryam R.
|
|
|
169 |
C |
p.
|
article
|
| 11 |
Hadrontherapy techniques for breast cancer
|
Loap, Pierre
|
|
|
169 |
C |
p.
|
article
|
| 12 |
High dose chemotherapy followed by autologous hematopoietic stem cell transplantation for advanced germ cell tumors: State of the art and a single-center experience
|
Pierantoni, Francesco
|
|
|
169 |
C |
p.
|
article
|
| 13 |
Immuno-oncology therapy in metastatic bladder cancer: A systematic review and network meta-analysis
|
Chierigo, Francesco
|
|
|
169 |
C |
p.
|
article
|
| 14 |
Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper
|
Natalicchio, Annalisa
|
|
|
169 |
C |
p.
|
article
|
| 15 |
Neoadjuvant immunotherapy in head and neck cancer: Rationale, current evidence and future perspective
|
Cabezas-Camarero, Santiago
|
|
|
169 |
C |
p.
|
article
|
| 16 |
Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study
|
Pisapia, Pasquale
|
|
|
169 |
C |
p.
|
article
|
| 17 |
Obesity and prostate cancer: A narrative review
|
Wilson, Rebekah L.
|
|
|
169 |
C |
p.
|
article
|
| 18 |
Prediction performance of twelve tumor mutation burden panels in melanoma and non-small cell lung cancer
|
Xu, Dechen
|
|
|
169 |
C |
p.
|
article
|
| 19 |
Prognostic factors in salvage surgery for recurrent head and neck cancer: A systematic review and meta-analysis
|
Lupato, Valentina
|
|
|
169 |
C |
p.
|
article
|
| 20 |
Prognostic role of cell-free DNA biomarkers in pancreatic adenocarcinoma: A systematic review and meta–analysis
|
Bunduc, Stefania
|
|
|
169 |
C |
p.
|
article
|
| 21 |
Pseudoprogression in lung cancer patients treated with immunotherapy
|
Chen, Meng-Yu
|
|
|
169 |
C |
p.
|
article
|
| 22 |
Radiotherapy and radiosensitization in breast cancer: Molecular targets and clinical applications
|
Bhat, Vasudeva
|
|
|
169 |
C |
p.
|
article
|
| 23 |
Role of EZH2 in bone marrow mesenchymal stem cells and immune–cancer interactions
|
Liu, Zhaoyun
|
|
|
169 |
C |
p.
|
article
|
| 24 |
State of the art of radiomic analysis in the clinical management of prostate cancer: A systematic review
|
Ghezzo, Samuele
|
|
|
169 |
C |
p.
|
article
|
| 25 |
Targeted protein degraders from an oncologist point of view: The Holy Grail of cancer therapy?
|
Ambrosini, Margherita
|
|
|
169 |
C |
p.
|
article
|
| 26 |
Targeting the metabolism of cancer stem cells by energy disruptor molecules
|
Dadgar, Tahere
|
|
|
169 |
C |
p.
|
article
|
| 27 |
The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies
|
Russo, Antonio
|
|
|
169 |
C |
p.
|
article
|
| 28 |
The current landscape of systemic therapy for recurrent glioblastoma: A systematic review of randomized-controlled trials
|
Fazzari, Francesco G.T.
|
|
|
169 |
C |
p.
|
article
|
| 29 |
The storm of NGS in NSCLC diagnostic-therapeutic pathway: How to sun the real clinical practice
|
De Maglio, Giovanna
|
|
|
169 |
C |
p.
|
article
|
| 30 |
Which treatment after first line therapy in NSCLC patients without genetic alterations in the era of immunotherapy?
|
Insa, Amelia
|
|
|
169 |
C |
p.
|
article
|
| 31 |
Willingness to pay for high-quality remote radiation oncology training in Latin America
|
Li, Benjamin
|
|
|
169 |
C |
p.
|
article
|
Journal description